10/2/2014 | CVLM | InterMune makes make-whole fundamental change offer for convertibles
|
9/29/2014 | CV | InterMune convertibles settle in cash after acquisition by Roche
|
9/5/2014 | CVLM | InterMune: Merger to trigger fundamental change under 5% convertibles
|
8/27/2014 | CV | Market Commentary: Aegerion adds on swap with higher shares; Titan Machinery slips on swap on lower shares
|
8/26/2014 | CV | Market Commentary: Priceline, Illumina trade in line; Medivation, Isis in focus; Prospect Capital bid lower
|
8/25/2014 | CV | Market Commentary: InterMune jumps on Roche buyout news; Illumina in line; Qihoo finds buyers on stock dip
|
8/25/2014 | CV | Market Commentary: Morning Commentary: InterMune surges outright on takeout; Illumina in line; Qihoo in demand
|
8/13/2014 | CV | Market Commentary: Convertibles weaker; Apollo drops with add-on; Ligand, EnerNOC flattish; planned AOL eyed
|
6/25/2014 | CVLM | InterMune exchanges $43.1 million of 2.5% convertibles at discount
|
5/21/2014 | CV | Market Commentary: American Realty lower in line; InterMune active since drug data; Cobalt trades in line
|
2/26/2014 | CV | Market Commentary: Midday Commentary: UTi Worldwide launches $350 million convertible deal, shares plunge
|
2/25/2014 | CV | Market Commentary: Midday Commentary: InterMune skyrockets on positive trial data; Stone Energy quiet after earnings
|
2/25/2014 | CV | Market Commentary: InterMune surges on trial data; Tesla, Chart Industries 'come in'; Stone Energy in line
|
2/3/2014 | CV | Market Commentary: Convertibles weaken; Herbalife's planned $1 billion offering in focus; InterMune sinks
|
1/31/2014 | CV | Market Commentary: DFC Global bonds drop after weak earnings; InterMune paper 'holds in' despite stock drop
|
1/10/2014 | CV | Market Commentary: Alcoa drops outright, slips on hedge after earnings; Home Inns a little better; YRC eyed
|
1/9/2014 | CV | Market Commentary: Sequenom jumps outright, adds on hedge; InterMune adds in line; Endeavour up a point
|
2/19/2013 | CV | Market Commentary: Central European Distribution jumps; AMR up; Cliff mandatory flat; Post, Forestar on tap
|
1/22/2013 | CV | InterMune greenshoe ups 2.5% convertibles due 2017 to $120.75 million
|
1/17/2013 | CV | Market Commentary: New Pacira surges on debut; planned Theravance seen cheap; planned Solazyme lacks borrow
|
1/16/2013 | CV | New Issue: InterMune sells upsized $105 million five-year convertibles to yield 2.5%, up 30%
|
1/16/2013 | CV | Market Commentary: InterMune notches stellar debut; Pacira sees revised terms; Cobalt steady dollar neutral
|
1/15/2013 | CV | Market Commentary: Amgen sees sellers ahead of maturity; Gilead Ds better; Lennar slips; Pacira to price
|
1/14/2013 | CV | InterMune to sell $85 million four-year convertibles to yield 3.125%-3.625%, up 25%-30%
|
1/14/2013 | CV | Market Commentary: Dendreon adds outright; InterMune intends to price notes, shares; Lennar earnings on tap
|
12/17/2012 | CVHYPF | InterMune files $300 million shelf covering stock, preferreds, debt
|
7/23/2012 | CV | Market Commentary: Convertibles mostly quiet: Kodak drops sharply after negative ruling; Onyx adds on hedge
|
9/19/2011 | CV | InterMune greenshoe exercised, lifting convertibles to $155.25 million
|
9/15/2011 | CV | Market Commentary: Suntech, JA Solar fall on downgrades; InterMune continues rising; EMC, Amgen climb higher
|
9/14/2011 | CV | Market Commentary: Textron rises on tender; Intermune gains on debut despite tighter talk; Avis up as bid pulled
|
9/13/2011 | CV | New Issue: InterMune prices $135 million 2.5% convertibles due 2018, up 32.5%
|
9/13/2011 | CV | Market Commentary: InterMune looks rich on revised terms; US Airways' premium comes in a point; Best Buy dips
|
9/12/2011 | CVHYPF | InterMune files automatic shelf covering debt, stock and preferreds
|
9/12/2011 | CV | InterMune to sell $100 million seven-year convertibles to yield 3.25%-3.75%, up 27.5%-32.5%
|
9/12/2011 | CV | Market Commentary: Global Industries surges on takeover offer; Hornbeck up 2-3 points; Clearwire weakens
|
12/17/2010 | CV | Market Commentary: InterMune gains outright; lighter delta yields better hedge move; MGIC, NuVasive active
|
5/5/2010 | CV | Market Commentary: InterMune drops on FDA rejection, but hedgies do OK; American Medical convertibles richen
|
9/24/2009 | CV | InterMune agrees to issue shares for 0.25% convertible senior notes
|
9/4/2009 | CVHY | InterMune files $200 million stock, warrants, preferreds, debt shelf
|
4/3/2009 | CV | InterMune agrees to issue shares for $32.25 million of convertibles
|
6/10/2008 | CV | InterMune to exchange $85 million 5% convertibles for its 0.25% convertibles
|
12/29/2006 | CVHY | InterMune files $175 million debt, stock shelf
|
11/29/2005 | CV | Market Commentary: Calpine convertibles drop after ouster; InterMune adds on hedge; Frontier Airlines launches deal
|
1/12/2005 | CV | Market Commentary: Level 3 higher on job cuts; CenturyTel off; Kodak up; Advanced Micro rebounds
|
11/11/2004 | CV | Market Commentary: GenCorp buyout bid hurts hedged holders; CenterPoint, Penn Treaty up; InterMune off
|
3/12/2004 | CV | InterMune buys back $52.5 million 5.75% convertibles
|
2/11/2004 | CV | New Issue: InterMune sells $150 million convertible at 0.25%, up 17.5%
|
2/11/2004 | CV | Market Commentary: Disney steals show; Echostar cast as takeover target, too; Safeguard advanced
|
2/10/2004 | CV | Market Commentary: New deals active; Solectron loses 0.5 point; AMR reoffered at 98.5; CuraGen, InterMune ahead
|
2/9/2004 | CV | InterMune $150 million mandatory convertible talked at 0.0-0.5%, up 15-20%
|
2/9/2004 | CV | Market Commentary: Calpine 4s add 1.25 points on tender; Juniper whacked 11.25 points; four deals tossed to market
|
1/9/2003 | CV | Market Commentary: Cendant gets boost from straight bond deal, Tyco putable issues gain sharply
|
1/8/2003 | CV | Market Commentary: Tyco dominates trading day, power issues surge on manipulation suit dismissal
|
1/7/2003 | CV | Market Commentary: Heavy trading on Tyco deal; InterMune dives, techs and telecoms soar, power mixed
|
8/28/2002 | CV | Market Commentary: Nortel drags down networkers; Semtech pressures chip group
|
3/1/2002 | CV | Market Commentary: Convertibles bounce but new paper lags
|